Literature DB >> 1971976

A physician's guide to discontinuing benzodiazepine therapy.

R L DuPont1.   

Abstract

Practicing physicians need to have practical techniques to help patients who want to stop using benzodiazepines. I have developed three approaches that usually work. The first, and most widely applicable, is gradually reducing the dose without adding any other medicine. Failing this, use one of the following two approaches, occasionally combining them: switch to a longer-acting, cross-tolerant medication (usually clonazepam or phenobarbital) or use medications to suppress the withdrawal symptoms, usually carbamazepine, propranolol, or clonidine. If this fails, use inpatient detoxification. Chemically dependent patients, including those abusing alcohol and taking higher than recommended doses of sedative-hypnotics, require special care during discontinuation. Aftercare is important for all long-term benzodiazepine users if they are to remain drug-free and live relatively comfortable lives.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1971976      PMCID: PMC1002417     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  5 in total

1.  Detoxification with phenobarbital of alprazolam-dependent polysubstance abusers.

Authors:  N V Ravi; I Maany; W M Burke; V Dhopesh; G E Woody
Journal:  J Subst Abuse Treat       Date:  1990

2.  Benzodiazepine dependency syndromes.

Authors:  D E Smith; D R Wesson
Journal:  J Psychoactive Drugs       Date:  1983 Jan-Jun

3.  Effects of transdermal clonidine treatment on withdrawal symptoms associated with smoking cessation. A randomized, controlled trial.

Authors:  S A Ornish; S Zisook; L A McAdams
Journal:  Arch Intern Med       Date:  1988-09

4.  The alprazolam to clonazepam switch for the treatment of panic disorder.

Authors:  J B Herman; J F Rosenbaum; A W Brotman
Journal:  J Clin Psychopharmacol       Date:  1987-06       Impact factor: 3.153

5.  Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.

Authors:  J C Pecknold; R P Swinson; K Kuch; C P Lewis
Journal:  Arch Gen Psychiatry       Date:  1988-05
  5 in total
  1 in total

Review 1.  Metabolic diversity as a reason for unsuccessful detoxification from benzodiazepines: the rationale for serum BZD concentration monitoring.

Authors:  Anna Basińska-Szafrańska
Journal:  Eur J Clin Pharmacol       Date:  2021-01-03       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.